Cardiotonic composition

Details Cardiotonic composition Cardiotonic composition

A - Human Necessities

61

K

167/199

A61K 9/48 (2006.01)

Patent

CA 1046410

ABSTRACT OF THE DISCLOSURE A cardiotonic dosage unit form comprises a soft gelatine capsule containing a liquid cardiotonic composition comprising (a) a cardiac glycoside, preferably digitoxin or digoxin; (b) dimethyl formamide or dimethyl acetamide; and (c) a liquid polyethylene glycol and also, optionally, (d) propylene glycol or glycerin. The weight ratio of dimethyl acetamide or dimethyl formamide to cardiac glyceride is from 5:1 to 15:1 and the polyethylene glycol forms at least 75% by weight of the total composition contained in the gelatine capsule.

223484

Affiliated with

Also associated with

Rating

Cardiotonic composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cardiotonic composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiotonic composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-377785